Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered
• 1.4 Market Analysis by Type
  • 1.4.1 Global Aliskiren Market Size Growth Rate by Type (2014-2025)
  • 1.4.2 150 mg Tablet
  • 1.4.3 300 mg Tablet
• 1.5 Market by Application
  • 1.5.1 Global Aliskiren Market Share by Application (2014-2025)
  • 1.5.2 Hospital
  • 1.5.3 Drug store
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Aliskiren Market Size
• 2.2 Aliskiren Growth Trends by Regions
  • 2.2.1 Aliskiren Market Size by Regions (2014-2025)
  • 2.2.2 Aliskiren Market Share by Regions (2014-2019)
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Opportunities

3 Market Share by Key Players

• 3.1 Aliskiren Market Size by Manufacturers
  • 3.1.1 Global Aliskiren Revenue by Manufacturers (2014-2019)
  • 3.1.2 Global Aliskiren Revenue Market Share by Manufacturers (2014-2019)
  • 3.1.3 Global Aliskiren Market Concentration Ratio (CR5 and HHI)
• 3.2 Aliskiren Key Players Head office and Area Served
• 3.3 Key Players Aliskiren Product/Solution/Service
• 3.4 Date of Enter into Aliskiren Market
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

• 4.1 Global Aliskiren Market Size by Type (2014-2019)
• 4.2 Global Aliskiren Market Size by Application (2014-2019)

5 United States

• 5.1 United States Aliskiren Market Size (2014-2019)
• 5.2 Aliskiren Key Players in United States
• 5.3 United States Aliskiren Market Size by Type
• 5.4 United States Aliskiren Market Size by Application

6 Europe

• 6.1 Europe Aliskiren Market Size (2014-2019)
• 6.2 Aliskiren Key Players in Europe
• 6.3 Europe Aliskiren Market Size by Type
• 6.4 Europe Aliskiren Market Size by Application

7 China

• 7.1 China Aliskiren Market Size (2014-2019)
• 7.2 Aliskiren Key Players in China
• 7.3 China Aliskiren Market Size by Type
• 7.4 China Aliskiren Market Size by Application

8 Japan

• 8.1 Japan Aliskiren Market Size (2014-2019)
• 8.2 Aliskiren Key Players in Japan
• 8.3 Japan Aliskiren Market Size by Type
• 8.4 Japan Aliskiren Market Size by Application

9 Southeast Asia

• 9.1 Southeast Asia Aliskiren Market Size (2014-2019)
• 9.2 Aliskiren Key Players in Southeast Asia
• 9.3 Southeast Asia Aliskiren Market Size by Type
• 9.4 Southeast Asia Aliskiren Market Size by Application

10 India

• 10.1 India Aliskiren Market Size (2014-2019)
• 10.2 Aliskiren Key Players in India
• 10.3 India Aliskiren Market Size by Type
• 10.4 India Aliskiren Market Size by Application

11 Central & South America

• 11.1 Central & South America Aliskiren Market Size (2014-2019)
• 11.2 Aliskiren Key Players in Central & South America
• 11.3 Central & South America Aliskiren Market Size by Type
• 11.4 Central & South America Aliskiren Market Size by Application

12 International Players Profiles

• 12.1 Noden Pharma
  • 12.1.1 Noden Pharma Company Details
  • 12.1.2 Company Description and Business Overview
  • 12.1.3 Aliskiren Introduction
  • 12.1.4 Noden Pharma Revenue in Aliskiren Business (2014-2019)
  • 12.1.5 Noden Pharma Recent Development

13 Market Forecast 2019-2025

• 13.1 Market Size Forecast by Regions
• 13.2 United States
• 13.3 Europe
• 13.4 China
• 13.5 Japan
• 13.6 Southeast Asia
• 13.7 India
• 13.8 Central & South America
• 13.9 Market Size Forecast by Product (2019-2025)
• 13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 12.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Disclaimer

Aliskiren (trade names Tekturna and Rasilez) is the first in a class of drugs called direct renin inhibitors. It is used for essential (primary) hypertension.
In 2018, the global Aliskiren market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Aliskiren status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Aliskiren development in United States, Europe and China.

The key players covered in this study
Noden Pharma
...

Market segment by Type, the product can be split into
150 mg Tablet
300 mg Tablet

Market segment by Application, split into
Hospital
Drug store

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Aliskiren status, future forecast, growth opportunity, key market and key players.
To present the Aliskiren development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Aliskiren are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.